The transcription factors IRF3 and NF-kB are required for the expression of many genes involved in antiviral innate immune response, including type I interferons (IFNs) and proinflammatory cytokines. It is well established that TBK1 is an essential kinase engaged downstream of multiple pattern-recognition receptors (PRRs) to mediate IRF3 phosphorylation and activation, whereas the precise mechanisms of TBK1 activation have not been fully elucidated yet. Here, we identified tripartite motif 26 (TRIM26) as an important regulator for RNA virus-triggered innate immune response. Knockdown of TRIM26 impaired virus-triggered IRF3, NF-kB activation, IFN-b induction, and cellular antiviral response. TRIM26 was physically associated with TBK1 independent of viral infection. As an E3 ligase, TRIM26 underwent autoubiquitination upon viral infection. Ubiquitinated TRIM26 subsequently associated with NEMO, thus bridging TBK1-NEMO interaction, which is critical for the recruitment of TBK1 to the VISA signalsome and activation of TBK1. Our findings suggest that TRIM26 is an important regulator of innate immune responses against RNA viruses, which functions by bridging TBK1 to NEMO and mediating the activation of TBK1.
Introduction
The innate immune response acts as the first line of host defense against viral infection. Germ line-encoded pattern-recognition receptors (PRRs) of the innate immune system recognize pathogenassociated molecular patterns (PAMPs) derived from invading viruses, such as nucleic acids, which triggers a series of cellular events, leading to the induction of type I interferons (IFNs) and proinflammatory cytokines (Janeway and Medzhitov, 2002; Akira et al., 2006) . Type I IFNs further induce expressions of a range of downstream antiviral IFN-stimulated genes (ISGs) through the JAK-STAT signaling pathways, leading to the establishment of an antiviral status (Janeway and Medzhitov, 2002; Stetson and Medzhitov, 2006) .
In the case of RNA virus infection, viral RNAs generated during replication are recognized by at least two classes of PRRs, including membrane-bound Toll-like receptors (TLRs) that mainly function in immune cells such as dendritic cells, macrophages, and B cells, and cytosolic RIG-I-like receptors (RLRs) that function in much broader cell types (Akira et al., 2006) . In most cell types, cytosolic viral RNA is recognized by RIG-I-like receptors (RLRs), including RIG-I, MDA5, and LGP2 (Pichlmair and Reis e Sousa, 2007) . Upon binding to viral RNAs, RIG-I and MDA5 are recruited to the mitochondrial adaptor protein VISA (also known as MAVS, IPS-1, and Cardif), which serves as a platform to assemble a signalsome containing multiple proteins, including E3 ligases such as TRAF2/3/5/6 and TRIM14 (Kawai et al., 2005; Seth et al., 2005; Xu et al., 2005; Zhou et al., 2014b) . These E3 ligases undergo autoubiquitination or mediate ubiquitination of other signaling factors, resulting in formation of polyubiquitination chains. It has been demonstrated that polyubiquitination chains are critical for the recruitment of NEMO (NF-kB essential modulator, also known as IKKg), a member of the IKK complex (Ea et al., 2006) . NEMO further recruits IKK complex as well as the kinases TBK1/IKK1, leading to the activation of the transcription factors NF-kB and IRF3, respectively (Zhao et al., 2007) . Activated NF-kB and IRF3 then collaborate to induce the productions of type I IFNs and proinflammatory cytokines.
The production of type I IFNs is delicately regulated by the host to ensure immune homeostasis. Ubiquitination and deubiquitination play important roles in the regulation of virus-triggered induction of type I IFNs (Malynn and Ma, 2010) . Ubiquitination is a series of reactions mainly mediated by three kinds of enzymes: the E1 activating enzyme, E2 conjugating enzyme, and the E3 ligase. It is the particular combination of an E2 and an E3 that determines the substrate specificity and the type of polyubiquitin chains formed (Pickart, 2001) . It has been demonstrated that different types of polyubiquitin chains predict different fates of the substrate. In most cases, K48-linked polyubiquitin chain targets the substrates for proteasomedependent degradation, whereas K63-linked polyubiquitin chain exerts positive regulatory effects (Bibeau-Poirier and Servant, 2008; Malynn and Ma, 2010) . Increasing evidence suggest that other types of polyubiquitin chains also participate in antiviral innate immunity, such as K11-, K27-linked, as well as linear polyubiquitin chains (Skaug et al., 2009; Arimoto et al., 2010; Belgnaoui et al., 2012; Qin et al., 2014; Wang et al., 2014) .
The tripartite motif (TRIM) family proteins contain RING domain, thus are theoretically E3 ubiquitin ligases (Skaug et al., 2009) . In recent years, an increasing number of studies have demonstrated that the TRIM family proteins are engaged in a broad range of biological processes involved in innate immunity, including viral restriction and regulation of immune signaling pathways (Ozato et al., 2008; Rajsbaum et al., 2008; McNab et al., 2011; Versteeg et al., 2013 Versteeg et al., , 2014 Hu et al., 2014; Yan et al., 2014) . In line with their important roles in immune regulation, the expressions of many TRIMs are induced by type I and type II interferons (Ozato et al., 2008; Rajsbaum et al., 2008; Versteeg et al., 2014) . Most of TRIMs function as E3 ligases and mediate ubiquitination-related regulations. For example, TRIM25-mediated, K63-linked ubiquitination of RIG-I arguments IFN-b production and antiviral responses, whereas TRIM30a-mediated ubiquitination and degradation of TAB2 and TAB3 negatively regulates TLR-mediated NF-kB activation (Shi et al., 2008) . Other TRIMs, such as TRIM14, TRIM15, TRIM21, TRIM32, TRIM44, and TRIM56, have also been reported to regulate adaptors VISA-or MITA-mediated IRF3 activation (BibeauPoirier and Servant, 2008; Arimoto et al., 2010; Tsuchida et al., 2010; Zhang et al., 2012; Zhou et al., 2014b) .
Ubiquitination plays as critical regulatory mechanism for virustriggered induction of type I IFNs. In this study, to identify undefined ubiquitination-related mechanisms involved in the regulation of virus-triggered induction of type I IFNs, we screened a cDNA array containing 352 expression clones of ubiquitination-related enzymes. We identified tripartite motif protein 26 (TRIM26) as a positive regulator of virus triggered signaling. TRIM26 potentiates virus-triggered IRF3, NF-kB activation, IFN-b induction, and cellular antiviral responses. Further investigation suggests that TRIM26 plays an important role in the antiviral innate immune response by bridging TBK1 to NEMO and mediating TBK1 activation.
Results

Identification of TRIM26 as a positive regulator of RNA virus-triggered induction of type I IFNs
To further elucidate the mechanisms of ubiquitination-related regulation of virus-triggered induction of type I IFNs, we performed expression screening to identify ubiquitin-related enzymes involved in the induction of type I IFNs. We screened a cDNA array containing 352 expression clones of ubiquitin-related enzymes by IFN-b promoter reporter assays. These efforts led to the identification of TRIM26, a member of the TRIM family protein, as a positive regulator ( Figure 1A) . Overexpression of TRIM26 potentiated IFN-b promoter activation induced by transfected intracellular poly(I:C) ( Figure 1A) . Interestingly, TRIM26 dose-dependently potentiated cytoplasmic poly(I:C)-and SeV-induced activation of the IFN-b promoter when transfected at low dosages (no more than 50 ng) ( Figure 1B) . However, when transfected at higher dosages (100 ng and above), TRIM26 inhibited cytoplasmic poly(I:C)-, SeV-, as well as RIG-I-, MDA5-, and VISA-induced activation of the IFN-b promoter (Supplementary Figure S1A and B). In the same experiments, TRIM26(C31S), a mutant which lacks the E3 ligase activity, failed to augment these antiviral response at any tried dosages, suggesting the E3 ligase activity of TRIM26 is required for its full ability to positively regulate virus-triggered induction of type I IFNs ( Figure 1B) . In HeLa cells, overexpression of TRIM26 only potentiated SeV-but not HSV-1-induced the IFN-b promoter activation, indicating TRIM26 specifically regulates RNA virus-induced IFN-b production ( Figure 1C ). In addition, TRIM26 had no effects on TLR3-mediated signaling transduction ( Figure 1D) . Previously, it has been reported that many TRIMs are IFN-inducible (Ozato et al., 2008; Rajsbaum et al., 2008) . In our experiments, we found that the mRNA level of TRIM26 was markedly induced by SeV-, HSV-1-infection as well as treatment with recombinant IFN-b in different cell types, suggesting that TRIM26 is a type I IFN-stimulated gene ( Figure 1E ). Taken together, these data suggest that TRIM26 is an ISG which functions as a positive regulator of RNA virus-triggered induction of IFN-b.
TRIM26 is essential for RNA virus-triggered signaling
To determine whether endogenous TRIM26 is essential for virustriggered type I IFN production, we constructed three RNAi plasmids for TRIM26. These RNAi plasmids reduced the expression of transfected and endogenous TRIM26 in 293T cells to different levels as shown in Figure 2A . Reporter assays indicated that knockdown of endogenous TRIM26 inhibited SeV-and cytoplasmic poly(I:C)-triggered activation of the IFN-b promoter ( Figure 2B ). The degrees of inhibition were correlated with the efficiencies of TRIM26 knockdown by the three RNAi plasmids (Figure 2A and B) . Notably, the #3 TRIM26-RNAi which barely knocked down the expression of TRIM26 somehow affected the basal activity of the IFN-b promoter, resulting in a 1.56-fold increase of the activity of the IFN-b promoter in untreated cells. Upon poly(I:C) transfection, although the activity of the IFN-b promoter in #3 TRIM26-RNAi transfected cells appeared higher than that of the control, the induction fold of the IFN-b promoter activity did not increase. Since induction of IFN-b requires the cooperation of transcription factors NF-kB and IRF3 (Maniatis et al., 1998) , we then examined the effects of TRIM26 on NF-kB and IRF3 activation respectively. Reporter assays indicated that knockdown of TRIM26 inhibited both NF-kB and ISRE activation triggered by SeV infection ( Figure 2C ). However, knockdown of TRIM26 had no effects on TNFa-induced NF-kB activation ( Figure 2D ). Since the #1 TRIM26-RNAi plasmid displayed the highest knockdown efficiency, it was used for all the following experiments and similar results were obtained with the #2 TRIM26-RNAi plasmid. Consistently, knockdown of TRIM26 also significantly inhibited SeV-and cytoplasmic poly(I:C)-triggered transcription of endogenous IFNB1, ISG56 and TNFa genes in 293T cells ( Figure 2E) . Similar results were obtained in THP-1, a human monocytic cell line ( Figure 2F ). In addition, knockdown of TRIM26 markedly inhibited SeV-induced phosphorylation of TBK1 and IRF3 ( Figure 2G ), as well as SeV-induced nuclear translocation of IRF3 ( Figure 2H and Supplementary Figure S2A) , which are the hallmarks of their activation. TRIM26 consists of 539 aa residues and shares 88% sequence identity with its murine ortholog. Knockdown of TRIM26 in MEFs also impaired SeV-induced transcription of Ifnb1 and Ifna1 (Supplementary Figure S2B) . Intriguingly, reconstitution of the TRIM26-RNAi resistant mutant of TRIM26 could reverse the inhibitory effect on SeV-induced IFN-b promoter activation caused by depletion of TRIM26 (Supplementary Figure S2C) .
To test whether TRIM26 participates in other signaling pathways, we examined the effects of TRIM26-RNAi on other PRR-mediated signaling. Depletion of TRIM26 had no effects on HSV-1-induced transcription of IFNB1 and ISG56 genes ( Figure 2F ). In addition, knockdown of TRIM26 had no marked effects on LPS-, IFN-b-or IFN-g-induced signaling (Supplementary Figure S2D -F). These data suggest that TRIM26 is specifically involved in RNA virustriggered, RLR-mediated induction of type I IFNs.
Since TRIM26 is important for viral infection-induced expression of the type I IFNs and its downstream ISGs, we next investigated the possible contribution of TRIM26 in cellular antiviral responses. Consistent with decreased type I IFN production, knockdown of TRIM26 significantly enhanced VSV and NDV replication in 293T Figure 3A and B) . In addition, cytoplasmic poly(I:C)-stimulated secretion of antiviral cytokines was also impaired in TRIM26 knockdown cells ( Figure 3C ). These observations suggest that TRIM26 is important in cellular antiviral responses against RNA viruses.
cells (
TRIM26 regulates virus-triggered signaling at the TBK1 level
A series of signaling components are involved in the induction of type I IFNs. To investigate at which levels does TRIM26 regulate virus-triggered signal transduction, we co-transfected TRIM26 with various signaling components and examined the effects of TRIM26 on their functions. As shown in Figure 4A and B, overexpression of TRIM26 potentiated activation of IFN-b promoter and ISRE mediated by TBK1 and its upstream components RIG-I, MDA5 and VISA, but not that of IRF3 or its constitutive active mutant IRF3-5D. Consistently, knockdown of TRIM26 had opposite effects ( Figure 4C and D) . Since RIG-I, MDA5 and VISA act upstream whereas IRF3 acts downstream of TBK1, the simplest explanation for these observations is that TRIM26 functions at the TBK1 level.
TRIM26 interacts with TBK1
Since TRIM26 functions at the TBK1 level, we then examined whether TRIM26 interacts with TBK1. In both 293T and THP-1 cells, endogenous coimmunoprecipitation experiments showed that TRIM26 interacted with TBK1 in the absence of viral infection ( Figure 5A) . Surprisingly, SeV infection impaired TRIM26-TBK1 interaction at 5 and 10 h post infection ( Figure 5A ). One possible explanation for this observation is that, upon viral infection, wildtype TBK1 undergoes auto-phosphorylation and activation and then dissociates from its binding partner TRIM26. To further test this hypothesis, we examined the interaction of TRIM26 and TBK1(K38A), a TBK1 mutant which lacks kinase activity therefore is unable to be activated. Consistent with our hypothesis, the interaction of TRIM26 with TBK1(K38A) was much stronger than expressing control or TRIM26-RNAi were infected with VSV (MOI ¼ 0.1), and the supernatants were harvested 24 h post infection followed by analysis of VSV production with standard plaque assay. Graphs show mean + SD. n ¼ 3. (B) Knockdown of TRIM26 potentiates NDV replication. 293T cells stably expressing control or TRIM26-RNAi were infected with NDV-GFP (MOI ¼ 0.1) for 48 h before virus replication was examined by fluorescence microscopy. Scale bar, 40 mm. (C) Knockdown of TRIM26 impairs cellular antiviral response. 293T cells stably expressing control or TRIM26-RNAi were transfected with poly(I:C). Twelve hours after transfection, the cell culture supernatants were transferred to the Vero cells. Twelve hours later, the supernatants were removed. Then the Vero cells were infected with VSV-GFP and NDV-GFP (MOI ¼ 0.1) for 36 h before virus replication was examined by fluorescence microscopy. Scale bar, 40 mm.
that with the wild type TBK1 ( Figure 5B ). Confocal microscopy also showed that colocalization of TRIM26 and TBK1(K38A) was well detected, whereas colocalization of TRIM26 and wild type TBK1 was too transient or weak to be detected (Supplementary Figure S3A) . Further investigation revealed that, the interaction between TRIM26 and TBK1(K38A) could be enhanced by SeV infection ( Figure 5C ), which also confirmed the hypothesis. It is well established that IKK1, another important kinase which functions cooperatively or redundantly with TBK1, could also mediate the phosphorylation and activation of IRF3. We next investigated whether TRIM26 also interacts with IKK1. When overexpressed, TRIM26 interacted with TBK1 but not IKK1 (Supplementary Figure S3B) , suggesting that TRIM26 interacts with TBK1 specifically.
Further domain-mapping investigations indicated that the C-terminal PRY-SPRY domain of TRIM26 was important for its interaction with TBK1 ( Figure 5D) , and the N-terminal kinase domain (KD) and ubiquitin like domain (ULD) of TBK1, were required for TBK1-TRIM26 interaction ( Figure 5E ). Notably, TRIM26(C31S), a mutant lacking the E3 ligase activity, interacted with TBK1 and TBK1(K38A) as well as wild-type TRIM26 ( Figure 5F ). Taken together, these data indicate that TRIM26 interacts with TBK1 independently of its E3 ligase activity under physiological conditions. After infection, TBK1 undergoes auto-phosphorylation and activation and then dissociates from its binding partner TRIM26.
TRIM26 undergoes autoubiquitination upon viral infection
Since TRIM26 is an E3 ligase and the TRIM26(C31S) mutant which lacks the E3 ligase activity lost its ability to positively regulate virustriggered induction of type I IFNs ( Figure 1B) , we examined whether TRIM26 mediates ubiquitination of TBK1 and other components of the VISA signalsome. In ubiquitination assays, cotransfection of TRIM26 had no obvious effects on the ubiquitination of TBK1 as well as RIG-I, MDA5, VISA, or NEMO (Supplementary Figure S4A , B, and data not shown). Intriguingly, we found that in similar experiments, wild type TRIM26 was heavily ubiquitinated, whereas the ubiquitination of TRIM26(C31S) was undetectable, suggesting TRIM26 may undergo self-ubiquitination. To further test this, we cotransfected non-tagged wild-type TRIM26 with Flag-TRIM26(C31S) and found that in presence of wild-type TRIM26, the ubiquitination of TRIM26(C31S) was restored ( Figure 6A) . Notably, in the same experiment, non-tagged TRIM26 was immunopricipitated with Flag-tagged TRIM26 ( Figure 6A ), indicating that TRIM26 could undergo oligomerization. To exclude the possibility that the observed ubiquitination of Flag-TRIM26(C31S) occurred on the associated wild-type TRIM26, we denatured the cell lysates by treatment with 1% SDS containing lysis buffer at 958C for 10 min to disturb protein interaction before ubiquitination assay was performed. The results confirmed that in presence of wild-type TRIM26, TRIM26(C31S) was indeed ubiquitinated ( Figure 6A) . In vitro ubiquitination assays also confirmed the autoubiquitination of TRIM26 (Supplementary Figure S4C) . We next examined the ubiquitination of endogenous TRIM26. We found that TRIM26 was slightly ubiquitinated under physiological conditions, whereas SeV infection markedly increased its ubiquitination ( Figure 6B ). Although the expression of TRIM26 could be induced by viral infection, the protein level of TRIM26 barely changed at 4 h post SeV infection, suggesting the increased ubiquitination of TRIM26 was not due to the induced expression of TRIM26. We next investigated the type of ubiquitination mediated by TRIM26 and found that TRIM26 promoted mainly K27-, and slightly K29-and K33-linked polyubiquitination of itself ( Figure 6C) . Consistently, the K27-linked polyubiquitination of endogenous TRIM26 was found to be increased 4 h after viral infection ( Figure 6D ). Taken together, these results suggest that TRIM26 undergoes K27-linked autoubiquitination after viral infection.
Ubiquitinated TRIM26 interacts with NEMO
As an E3 ligase, TRIM26 has not been found to mediate ubiquitination of any known members of the signalsome in our experiments. Yet the E3 ligase activity was required for its function as a positive regulator. Therefore, we speculated that instead of mediating ubiquitination of other signaling components which leads to their activation, the polyubiquitin chains generated in the process of TRIM26 autoubiquitination may serve as a platform to facilitate the assembly of the signalsome.
It has been well demonstrated that NEMO, an important member of the signalsome, has the ability of polyubiquitin binding. Therefore, we next examined whether TRIM26 interacted with NEMO. When overexpressed, TRIM26 interacted with NEMO and their interaction was further enhanced by SeV infection ( Figure 7A) . Endogenous coimmunoprecipitation experiments showed that TRIM26 barely interacted with NEMO under physiological conditions. However, their interaction was induced at 5 and 10 h after viral infection ( Figure 7B) . We further examined whether the E3 ligase activity of TRIM26 was required for its interaction with NEMO and found that only wild-type TRIM26 but not TRIM26(C31S) interacted with NEMO ( Figure 7C, short exposure) . Interestingly, on a film with long exposure, it was observed that ubiquitinated TRIM26 coimmunoprecipitated with NEMO ( Figure 7C , long exposure), suggesting that NEMO interacts with the polyubiquin chains of ubiquitinated TRIM26. To further test this, we examined the interaction of TRIM26 with NEMO(D311N), a mutant in which the polyubiquitinbinding activity is abolished (Wu et al., 2006) . As shown in Figure 7D , NEMO(D311N) failed to interact with TRIM26, indicating that NEMO interacts with TRIM26 through binding of polyubiquitin chains. Taken together, these data suggest that the polyubiquin chains of autoubiquitinated TRIM26 serve as a platform to recruit NEMO after viral infection.
TRIM26 bridges TBK1-NEMO interaction
Previously, NEMO has been established as a critical adaptor to recruit TBK1 to the VISA signalsome, which is essential for activation of TBK1 and IRF3/7 (Zhao et al., 2007; Zhou et al., 2014b) . Since TRIM26 interacted with both TBK1 and NEMO, we then tested whether TRIM26 could facilitate the TBK1-NEMO interaction. The results of coimmunoprecipitation experiments showed that overexpression of TRIM26 markedly enhanced TBK1 -NEMO interaction ( Figure 7E, lanes 1 and 2) . Consistently, knockdown of endogenous TRIM26 impaired virus-induced interaction of TBK1 and NEMO but had no effects on the interaction between IKKb and NEMO ( Figure 7F) . Interestingly, TBK1(K38A) interacted with NEMO much stronger than the wild type TBK1 ( Figure 7E, lane 1 and 4) , probably due to the dissociation of activated TBK1. Notably, the interaction between TBK1(K38A) and NEMO was also enhanced by TRIM26 ( Figure 7E, lane 4 and 5) . Since NEMO binds to the polyubiquitin chains of ubiquitinated TRIM26, we speculated that both the E3 ligase activity of TRIM26 and the polyubiquitin-binding activity of NEMO were required for the facilitation of TBK1-NEMO interaction. Consistent with our speculation, we found that TRIM26(C31S) failed to enhance the interaction of TBK1 or TBK1(K38A) with NEMO ( Figure 7E) . In addition, the interaction between TBK1 and NEMO(D311N) could not be augmented by TRIM26 ( Figure 7G, lane 3 and 4) .
Collectively, we propose the following model of TRIM26-mediated positive regulation of virus-triggered IRF3 activation. TRIM26 associates with TBK1 under physiological conditions. After viral infection, TRIM26 undergoes autoubiquitination. The polyubiquitin chains of autoubiquitinated TRIM26 serve as a platform to recruit NEMO, bringing TBK1 proximal to NEMO and facilitating the interaction of TBK1 with NEMO, which is essential for recruitment of TBK1 to the VISA signalsome and its activation. Once activated, TBK1 dissociates from TRIM26, phosphorylates IRF3, and induces the production of type I IFNs.
Discussion
It has been well demonstrated that the TBK1 plays critical roles in the signaling of virus-induced production of type I IFNs. However, how TBK1 is recruited to the VISA signalsome and activated remains to be elucidated. In this study, we identified TRIM26 as a positive regulator of RNA virus-triggered innate immune response. Overexpression of TRIM26 at low dosages potentiated SeV-and cytoplasmic poly(I:C)-triggered IFN-b production. In contrast, knockdown of endogenous TRIM26 impaired SeV-and cytoplasmic poly(I:C)-triggered IFN-b production as well as the cellular antiviral response. However, overexpression or knockdown of TRIM26 had no marked effects on extracellular poly(I:C)-, LPS-or HSV-1-induced IFN-b production, which were mediated by TLR3, TLR4, and DNA sensors respectively. In addition, TRIM26 also had no effects on the signaling induced by IFN-b. These data demonstrate that TRIM26 specifically facilitates RLR-mediated signaling.
There are several lines of evidence suggesting that TRIM26 functions at the TBK1 level. First, overexpression of TRIM26 potentiated ISRE activation mediated by TBK1 and its upstream components, but not its downstream factor IRF3 or IRF7, whereas knockdown of TRIM26 had opposite effects. Second, knockdown of TRIM26 impaired SeV-triggered phosphorylation of TBK1, suggesting TRIM26 functions upstream of IRF3. Third, both overexpression and endogenous coimmunoprecipitation experiments demonstrated the interaction of TRIM26 with TBK1 and NEMO, an important molecule required for TBK1 activation.
Intriguingly, viral infection displayed different effects on TRIM26-TBK1 and TRIM26-NEMO interaction. TRIM26 associated with TBK1 in the absence of viral infection, and their association was impaired after viral infection. In contrast, the interaction between TRIM26 and NEMO was viral infection-induced. The simplest explanation is that, after viral infection, TRIM26 recruits NEMO and facilitates TBK1-NEMO interaction, which is important for the activation of TBK1. Once activated, TBK1 then dissociates from TRIM26. This hypothesis is further supported by the observation that TBK1(K38A), a mutant which is unable to conduct auto-phosphorylation therefore cannot be activated, interacted with TRIM26 much stronger than the wild type TBK1 and their interaction could be further enhanced by viral infection. However, we cannot exclude other potential mechanism(s) which also regulate the interaction between TBK1 and TRIM26. For example, whether TRIM26 could be phosphorylated by TBK1 and whether such phosphorylation has any effect on their interaction.
In our study, we found that point mutation of a conserved Cys in the RING domain of TRIM26 abolished its ability to augment virus-induced production of IFN-b. We also found that both E3 ligase activity and the autoubiquitination of TRIM26 were important for the interaction of TRIM26 with NEMO but not with TBK1. Since NEMO has been demonstrated to bind polyubiquitin chains TRIM26 bridges TBK1 -NEMO interaction | 39 were left untreated or infected with SeV for 6 h. Coimmunoprecipitation and immunoblot analysis were performed with the indicated antibodies. (G) The poly-ubiquitin binding activity of NEMO is required for TRIM26 to facilitate the interaction between TBK1 and NEMO. These experiments were performed similarly as in E. (Husnjak and Dikic, 2012; Wang et al., 2012) , we speculate that the polyubiquitin chains conjugated to TRIM26 during its autoubiquitination mediated its interaction with NEMO. Therefore, ubiquitinated TRIM26, accompanied by its binding partner TBK1, recruits NEMO and bridges TBK1-NEMO interaction. Once TBK1 is recruited to the VISA signalsome and get activated, it then dissociates from TRIM26.
Previously, it has been reported that TRIM26 negatively regulates IFN-b production and antiviral response by degradation of nuclear IRF3 (Wang et al., 2015) . In this study, we found that TRIM26 positively regulates cytoplasmic dsRNA-induced expression of type I IFNs by facilitating TBK1-NEMO interaction. This discrepancy may due to the following reasons. First, the discrepancy may due to different dosages of TRIM26 used in gain of function experiments. In our experiments, we found that overexpression of TRIM26 at low dosages potentiated SeV-induced activation of the IFN-b promoter, whereas inhibited the activation of IFN-b promoter at high dosages ( Figure 1B and Supplementary Figure S1 ). Since TRIM26 is an E3 ligase, one possible explanation of these observations is that high levels of TRIM26 affects its substrate specificity, therefore causes off-target effects. Similar observations have been reported for some other molecules. For example, NEMO is a regulatory subunit required for IKK kinase activation. However, overexpression of NEMO at high dosages inhibits IKK-mediated NF-kB activation (Krappmann et al., 2000) .
Second, the discrepancy might be caused by different experimental systems used in these two studies. In our study, 293T, HeLa, THP-1 and MEFs were used in RNAi experiments and similar results were obtained in all these cells. However, all the loss of function experiments in the other study were performed with mouse peritoneal macrophages. It is possible that TRIM26 plays different functions in different cell types. Therefore additional studies, especially the investigations of TRIM26-deficient mice may resolve this discrepancy. Nevertheless, our findings provide insights on the mechanisms of TRIM26-mediated regulation of cellular antiviral response.
Materials and methods
Reagents and antibodies
Poly(I:C) (InvivoGen), recombinant TNFa, IFN-g (R&D Systems), IFN-b (ProSpec), and LPS (Sigma); lipofectamine 2000, and dualspecific luciferase assay kit (Promega); mouse monoclonal antibodies against Flag, b-actin (Sigma), HA (Origene), and TRIM26 (Santa Cruz Biotechnology); rabbit monoclonal antibodies against IRF3, phospho-IRF3 (Ser-396) (Santa Cruz Biotechnology), TBK1 and phospho-TBK1(Ser-172) (EPITOMICS) were purchased from the indicated manufacturers. Mouse multiclonal antibody against TRIM26 was raised against recombinant human C-terminal TRIM26 (aa 301-539). SeV, VSV, NDV-GFP, and HSV-1 were previously described (Lei et al., 2010; Zhou et al., 2014a) .
Constructs
ISRE, NF-kB, IRF1, and IFN-b promoter luciferase reporter plasmids, mammalian expression plasmids for HA-, Flag-tagged MDA5, RIG-I, RIG-IN, VISA, TBK1 and TBK1(K38A), IRF3, IRF3-5D, IRF7, NEMO, TANK were previously described (Xu et al., 2005; Zhong et al., 2008) . Mammalian expression plasmids for Flag-, HA-, cherry-, GFP-tagged TRIM26, TBK1, and their truncations and point mutants were constructed by standard molecular biology techniques.
Expression cloning
The cDNA expression clones encoding independent 352 ubiquitin-related enzymes were purchased from Origene. These clones were individually transfected into 293T cells together with the IFN-b promoter reporter plasmid. Twenty hours later, the cells were stimulated by transfection of poly(I:C) for 12 h, luciferase reporter assays were performed to identify clones that regulate cytoplasmic poly(I:C)-stimulated activation of the IFN-b promoter.
Transfection and reporter assays
The 293 cells (1 × 10 5 ) were seeded on 24-well plates and transfected the next day by standard calcium phosphate precipitation method. HeLa cells were transfected by lipofectamine 2000. Empty control plasmid was added to ensure that each transfection receives the same amount of total DNA. To normalize for transfection efficiency, 0.01 mg of pRL-TK (Renilla luciferase) reporter plasmid was added to each transfection. Luciferase assays were performed using a dual-specific luciferase assay kit.
Establishment of RNAi-transduced stable cell lines
The 293T cells were transfected with two packaging plasmids pGag-Pol and pVSV-G, and the plasmid for control or TRIM26-RNAi by calcium phosphate precipitation. Twelve hours after transfection cells were washed and fresh medium without antibiotics was added. Forty-eight hours later the cell culture medium containing recombinant virus was filtered and used to infect 293T or THP-1 cells in the presence of polybrene (8 mg/ml). The infected 293T or THP-1 cells were selected with puromycin (1.0 mg/ml) for 4 days before additional experiments were performed. In the case of MEFs, plasmids for control or TRIM26-RNAi were transfected into the Plat-E package cell line to general recombinant virus.
RNA interference
Double-strand oligonucleotides corresponding to the target sequences were cloned into the pSuper.Retro-RNAi plasmid (Oligoengine). The following sequences were targeted for human TRIM26 mRNA. #1: GAGACTTCCTAAACAGGTA; #2: GAAGTTCTGGG TTGGGAAA; #3: CAGCCGGGAGAGGTGACCC. For murine TRIM26 mRNA: GAGAATTCTCAGATAAACT.
Coimmunoprecipitation and immunoblot analysis
293T cells or THP-1 (5 × 10 6 for overexpression and 2 × 10 7 for endogenous experiments) were lysed in 1 ml NP-40 lysis buffer (20 mM Tris . HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride). Coimmunoprecipitation and immunoblot analysis were performed as previously described (Xu et al., 2005; Wei et al., 2015) .
In vitro ubiquitination assays
TRIM26 and HA-Ubiquitin were expressed with a TNT Quickcoupled Transcription/Translation Systems kit (Promega) following instructions of the manufacturer. Ubiquitination was analyzed with an ubiquitination kit (Enzo Life Science) following protocols recommended by the manufacturer.
Real-time PCR
Total RNA was isolated for real-time PCR analysis to measure mRNA levels of the indicated genes. Data shown are the relative abundance of the indicated mRNA normalized to that of GAPDH/ Gapdh. Gene-specific primer sequences were as follows. IFNB1: TTGTTGAGAACCTCCTGGCT (forward), TGACTATGGTCCAGGCACAG (reverse); ISG56: GCCTTGCTGAAGTGTGGAGGAA (forward), ATCCA GGCGATAGGCAGAGATC (reverse); TNFa: GCCGCATCGCCGTCTCC TAC (forward), CCTCAGCCCCCTCTGGGGTC (reverse); IFNA1: AGAA GGCTCCAGCCATCTCTGT (forward), TGCTGGTAGAGTTCGGTGCAGA (reverse); GAPDH: GAGTCAACGGATTTGGTCGT (forward), GACAAG CTTCCCGTTCTCAG (reverse); Ifnb1: TCCTGCTGTGCTTCTCCACCACA (forward), AAGTCCGCCCTGTAGGTGAGGTT (reverse); Ifna1: GGA TGTGACCTTCCTCAGACTC (forward), ACCTTCTCCTGCGGGAATCCAA (reverse); Gapdh: ACGGCCGCATCTTCTTGTGCA (forward), ACGGCC AAATCCGTTCACACC (reverse).
Virus manipulation
Viral infection was performed when cells were 70% confluent. The culture medium was replaced by serum-free DMEM, and then VSV and NDV-GFP was added into the medium at various multiplicities of infection (MOI) according to the specific experiments. After 1 h, the medium was removed, and the cells were fed with DMEM containing 10% FBS. The titers of VSV in supernatants were calculated by standard plaque assays, and the NDV-GFP replication in 293 cells was visualized by fluorescent microscopy (Ran et al., 2011; Zhang et al., 2012) .
Fluorescent confocal microscopy
HeLa cells were transfected with the indicated plasmids by lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, the cells were fixed with 4% paraformaldehyde for 10 min at room temperature. The cells were observed with an Olympus confocal microscope under a ×100 oil objective.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
